Drug-releasing device usable in mucosal body cavities
A tympanostomy tube containing a polymeric material and a drug is described. The polymeric material may comprise a non-resorbable polymer and a water-soluble polymer. The drug may be released when the device is contacted by an aqueous liquid such as middle ear exudate during otitis media. The implant may contain sufficient drug to treat multiple episodes of otitis media or to catch subsequent episodes in their early stages as a prophylactic. The device may be hydrophilic and further may contain a surfactant. The implant may be porous. The implant may have enhanced surface area at places exposed to middle ear liquid and may have enlarged mass so as to contain an increased total amount of drug. Intentional reorientation of the patient's head may aid in moving drug-containing liquid around the middle ear cavity. Similar implants can be used in other mucosal cavities.
1. A device for implantation into a mucosal bodily cavity having a volume of liquid and a volume of air therein, the device comprising:
a member comprising a polymeric material, a drug, and a surfactant, wherein said polymeric material, said drug, and said surfactant are blended together in a melt and formed into said device, and wherein said polymeric material comprises a substance selected from the group consisting of: polysilicones, silicones, polyurethanes, polyamides, natural rubber, synthetic elastomers, blends thereof, and mixtures thereof;
wherein said device has a geometry that fits inside but does not completely occupy said mucosal bodily cavity; and
wherein a surface of said device exhibits a contact angle with pure water that is less than 50 degrees.
2. The device of claim 1 , wherein said contact angle is less than 20 degrees.
3. The device of claim 1 , wherein said device is a tympanostomy tube having a long direction and having a hole therethrough along said long direction and formed from said member.
4. The device of claim 1 , wherein said polymeric material comprises a non-resorbable polymer and a water-soluble polymer.
5. The device of claim 1 , wherein said polymeric material or a component of said polymeric material is resorbable.
6. The device of claim 1 , wherein said device is porous.
7. The implant of claim 1 , wherein said surfactant produces wetting of said device with water or with a secreted liquid, said wetting having a contact angle of from 0 degrees to 10 degrees.
8. The implant of claim 1 , wherein said surfactant is selected from the group consisting of: sodium dodecyl sulfate; benzalkonium chloride;
poloxamer; pluronic; polysorbate; and Tyloxapol.
9. The device of claim 1 , wherein said drug comprises a member of the fluoroquinolone family of antibiotics.
10. The device of claim 1 , wherein drug comprises ciprofloxacin betaine.
11. The device of claim 10 , wherein the drug further comprises ciprofloxacin hydrochloride.
12. The device of claim 1 , wherein the member comprises a tubular member formed from said member.
13. The device of claim 1 , wherein said surfactant is not ototoxic.
14. The device of claim 1 , wherein said surfactant comprises an anionic surfactant, a cationic surfactant, or a nonionic surfactant.
15. The device of claim 1 , wherein said surfactant is selected to provide a surface tension on the surface of said device with an exudate of less than 60 dynes/cm.
16. The device of claim 1 , wherein said surfactant is selected to provide a surface tension on the surface of said device with an exudate of 60 dynes/cm to 40 dynes/cm.
17. A method of treating a patient, said method comprising:
(a) implanting a device in a mucosal cavity of the patient, said mucosal cavity having a volume of liquid and a volume of air therein, wherein the device comprises:
a member comprising a polymeric material, a drug, and a surfactant, wherein said polymeric material, said drug, and said surfactant are blended together in a melt and formed into said device, and wherein said polymeric material comprises a substance selected from the group consisting of: polysilicones, silicones, polyurethanes, polyamides, natural rubber, synthetic elastomers, blends thereof, and mixtures thereof;
wherein said device has a geometry that fits inside but does not completely occupy said mucosal cavity, and
wherein a surface of said device exhibits a contact angle with pure water that is less than 50 degrees; and
(b) causing or instructing said patient to change a bodily orientation of said patient between a first orientation and a second orientation, whereby in one of said orientations at least a portion of said device is exposed to said liquid that is present in said mucosal cavity, and in another of said orientations said device is not exposed to said liquid or is exposed to less of said liquid, whereby said drug is released when said liquid is in contact with said device.
18. The method of claim 17 , wherein the member comprises a tubular member formed from said member.
19. The method according to claim 17 , wherein said mucosal cavity comprises a middle ear.
20. The method according to claim 17 , wherein said mucosal cavity comprises an inner ear.
21. The method according to claim 17 , wherein said mucosal cavity comprises a sinus.
22. A device for implantation into a mucosal bodily cavity, said mucosal bodily cavity having a volume of liquid and a volume of air therein, said device comprising:
a member comprising a polymeric material, a drug, and a surfactant, said polymeric material, said drug, and said surfactant being blended together in a melt;
wherein said device has a geometry that fits inside but does not completely occupy said mucosal bodily cavity; and
wherein a surface of said device exhibits a contact angle with pure water that is less than 50 degrees.
23. The device according to claim 22 , wherein the member comprises a tubular member.
24. The device of claim 22 , wherein said surfactant is not ototoxic.
25. The device of claim 22 , wherein said surfactant comprises an anionic surfactant, a cationic surfactant, or a nonionic surfactant.
26. The device of claim 22 , wherein said surfactant is selected from the group consisting of: sodium dodecyl sulfate; benzalkonium chloride; poloxamer; pluronic; polysorbate; and Tyloxapol.
27. The device of claim 22 , wherein said surfactant is selected to provide a surface tension on the surface of said device with an exudate of less than 60 dynes/cm.
28. The device of claim 22 , wherein said surfactant is selected to provide a surface tension on the surface of said device with an exudate of 60 dynes/cm to 40 dynes/cm.